Showing posts with label — sashalatypova.substack.com "Due Diligence and Art" (@sasha_latypova) June 15. Show all posts
Showing posts with label — sashalatypova.substack.com "Due Diligence and Art" (@sasha_latypova) June 15. Show all posts

Saturday, June 15, 2024

LATYPOVA: There are no requirements for inspection of biologics manufacturing facilities by the FDA. This requirement was removed by Scott Gottlieb [per] admin rule change in 2019. Whatever is being produced is entirely open to adulteration, and this applies to all biologics, not just COVID

Elaborated here at Sasha Latypova's Substack